Lp(a) lipoprotein and plasminogen activity in patients with different etiology of ischemic stroke

Cerebrovascular Diseases

Volumn 23, Issue 2-3, 2007, Pages 188-193

  Petersen, Nils H ^a   Schmied, Alexander B ^a   Zeller, Jörn A ^a   Plendl, Hansjörg ^a   Deuschl, Günther ^a   Zunker, Peter ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Ischemic stroke; Lipoprotein(a); Plasminogen

Indexed keywords

LIPOPROTEIN A; PLASMINOGEN;

ADULT; AGED; ARTICLE; BRAIN ATHEROSCLEROSIS; BRAIN INFARCTION; CAUSAL ATTRIBUTION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DIAGNOSIS RELATED GROUP; FEMALE; HUMAN; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; STATISTICAL SIGNIFICANCE; STRUCTURAL HOMOLOGY; THROMBOGENESIS;

ACUTE DISEASE; ADULT; AGED; ATHEROSCLEROSIS; BRAIN ISCHEMIA; CASE-CONTROL STUDIES; CEREBROVASCULAR ACCIDENT; FEMALE; HEART DISEASES; HUMANS; INTRACRANIAL EMBOLISM; LIPOPROTEIN(A); LOGISTIC MODELS; MALE; MIDDLE AGED; PLASMINOGEN; RISK FACTORS;

EID: 33846909249     PISSN: 10159770     EISSN: None     Source Type: Journal    
DOI: 10.1159/000097640     Document Type: Article

References (42)

1. Gaubatz JW, Heideman C, Gotto AM Jr, Morrisett JD, Dahlen GH: Human plasma lipoprotein(a). Structural properties. J Biol Chem 1983;258:4582-4589.
2. McLean JW, Tomlinson JE, Kuang WJ, Eaton DL, Chen EY, Fless GM, Scanu AM, Lawn RM: cDNA sequence of human apolipoprotein(a) is homologous to plasminogen. Nature 1987;330:132-137.
3. Kostner GM, Bihari-Varga M: Is the atherogenicity of lp(a) caused by its reactivity with proteoglycans? Eur Heart J 1990;11(suppl E):184-189.
4. Beisiegel U, Niendorf A, Wolf K, Reblin T, Rath M: Lipoprotein(a) in the arterial wall. Eur Heart J 1990;11(suppl E):174-183.
5. de Rijke YB, Jurgens G, Hessels EM, Hermann A, van Berkel TJ: In vivo fate and scavenger receptor recognition of oxidized lipoprotein(a) isoforms in rats. J Lipid Res 1992;33:1315-1325.
6. Hajjar KA, Gavish D, Breslow JL, Nachman RL: Lipoprotein(a) modulation of endothelial cell surface fibrinolysis and its potential role in atherosclerosis. Nature 1989;339:303-305.
7. Loscalzo J, Weinfeld M, Fless GM, Scanu AM: Lipoprotein(a), fibrin binding, and plasminogen activation. Arteriosclerosis 1990;10:240-245.
8. Edelberg JM, Pizzo SV: Lipoprotein (a): the link between impared fibrinolysis and atherosclerosis. Fibrinolysis 1991;5:135-143.
9. Craig WY, Neveux LM, Palomaki GE, Cleveland MM, Haddow JE: Lipoprotein(a) as a risk factor for ischemic heart disease: meta-analysis of prospective studies. Clin Chem 1998;44:2301-2306.
10. Ariyo AA, Thach C, Tracy R: Lp(a) lipoprotein, vascular disease, and mortality in the elderly. N Engl J Med 2003;349:2108-2115.
11. Jurgens G, Koltringer P: Lipoprotein(a) in ischemic cerebrovascular disease: a new approach to the assessment of risk for stroke. Neurology 1987;37:513-515.
12. Jurgens G, Taddei-Peters WC, Koltringer P, Petek W, Chen Q, Greilberger J, Macomber PF, Butman BT, Stead AG, Ransom JH: Lipoprotein(a) serum concentration and apolipoprotein(a) phenotype correlate with severity and presence of ischemic cerebrovascular disease. Stroke 1995;26:1841-1848.
13. Woo J, Lau E, Lam CW, Kay R, Teoh R, Wong HY, Prall WY, Kreel L, Nicholls MG: Hypertension, lipoprotein(a), and apolipoprotein A-I as risk factors for stroke in the Chinese. Stroke 1991;22:203-208.
14. Zenker G, Koltringer P, Bone G, Niederkorn K, Pfeiffer K, Jurgens G: Lipoprotein(a) as a strong indicator for cerebrovascular disease. Stroke 1986;17:942-945.
15. Shintani S, Kikuchi S, Hamaguchi H, Shiigai T: High serum lipoprotein(a) levels are an independent risk factor for cerebral infarction. Stroke 1993;24:965-969.
16. Lindgren A, Nilsson-Ehle P, Norrving B, Johansson BB: Plasma lipids and lipoproteins in subtypes of stroke. Acta Neurol Scand 1992;86:572-578.
17. Nagayama M, Shinohara Y, Nagayama T: Lipoprotein(a) and ischemic cerebrovascular disease in young adults. Stroke 1994;25:74-78.
18. Cerrato P, Imperiale D, Fornengo P, Bruno G, Cassader M, Maffeis P, Cavallo Perin P, Pagano G, Bergamasco B: Higher lipoprotein (a) levels in atherothrombotic than lacunar ischemic cerebrovascular disease. Neurology 2002;58:653-655.
19. Ridker PM, Stampfer MJ, Hennekens CH: Plasma concentration of lipoprotein(a) and the risk of future stroke. JAMA 1995;273:1269-1273.
20. Glader CA, Stegmayr B, Boman J, Stenlund H, Weinehall L, Hallmans G, Dahlen GH: Chlamydia pneumoniae antibodies and high lipoprotein(a) levels do not predict ischemic cerebral infarctions. Results from a nested case-control study in northern Sweden. Stroke 1999;30:2013-2018.
21. Nguyen TT, Ellefson RD, Hodge DO, Bailey KR, Kottke TE, Abu-Lebdeh HS: Predictive value of electrophoretically detected lipoprotein(a) for coronary heart disease and cerebrovascular disease in a communitybased cohort of 9,936 men and women. Circulation 1997;96:1390-1397.
22. Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE 3rd: Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 1993;24:35-41.
23. Milionis HJ, Winder AF, Mikhailidis DP: Lipoprotein (a) and stroke. J Clin Pathol 2000;53:487-496.
24. Willeit J, Kiechl S, Santer P, Oberhollenzer F, Egger G, Jarosch E, Mair A: Lipoprotein(a) and asymptomatic carotid artery disease. Evidence of a prominent role in the evolution of advanced carotid plaques: the Bruneck study. Stroke 1995;26:1582-1587.
25. Jovicic A, Ivanisevic V, Ivanovic I: Lipoprotein(a) in patients with carotid atherosclerosis and ischemic cerebrovascular disorders. Atherosclerosis 1993;98:59-65.
26. Watts GF, Mazurkiewicz JC, Tonge K, Nelson V, Warburton FG, Slavin BM: Lipoprotein(a) as a determinant of the severity of angiographically defined carotid atherosclerosis. QJM 1995;88:321-326.
27. Marcucci R, Sofi F, Fedi S, Lari B, Sestini I, Cellai AP, Pulli R, Pratesi G, Pratesi C, Gensini GF, Abbate R: Thrombophilic risk factors in patients with severe carotid atherosclerosis. J Thromb Haemost 2005;3:502-507.
28. Arenillas JF, Molina CA, Chacon P, Rovira A, Montaner J, Coscojuela P, Sanchez E, Quintana M, Alvarez-Sabin J: High lipoprotein(a), diabetes, and the extent of symptomatic intracranial atherosclerosis. Neurology 2004;63:27-32.
29. Murai A, Miyahara T, Fujimoto N, Matsuda M, Kameyama M: Lp(a) lipoprotein as a risk factor for coronary heart disease and cerebral infarction. Atherosclerosis 1986;59:199-204.
30. Hobbs HH, White AL: Lipoprotein(a): intrigues and insights. Curr Opin Lipidol 1999;10:225-236.
31. Hachinski V, Graffagnino C, Beaudry M, Bernier G, Buck C, Donner A, Spence JD, Doig G, Wolfe BM: Lipids and stroke: a paradox resolved. Arch Neurol 1996;53:303-308.
32. van Kooten F, van Krimpen J, Dippel DW, Hoogerbrugge N, Koudstaal PJ: Lipoprotein(a) in patients with acute cerebral ischemia. Stroke 1996;27:1231-1235.
33. Nowak-Gottl U, Strater R, Heinecke A, Junker R, Koch HG, Schuierer G, von Eckardstein A: Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood 1999;94:3678-3682.
34. Peynet J, Beaudeux JL, Woimant F, Flourie F, Giraudeaux V, Vicaut E, Launay JM: Apolipoprotein(a) size polymorphism in young adults with ischemic stroke. Atherosclerosis 1999;142:233-239.
35. Kargman DE, Tuck C, Berglund L, Lin IF, Mukherjee RS, Thompson EV, Jones J, Boden-Albala B, Paik MC, Sacco RL: Lipid and lipoprotein levels remain stable in acute ischemic stroke: the Northern Manhattan Stroke Study. Atherosclerosis 1998;139:391-399.
36. Wehr H, Rado M, Mendel T, Swiderska M, Bednarska-Makaruk M, Szirkowiec W: Changes in lipoprotein (a) [Lp(a)] level after an ischemic stroke. Neurol Neurochir Pol 2004;38:197-200.
37. Miyata T, Iwanaga S, Sakata Y, Aoki N, Takamatsu J, Kamiya T: Plasminogens Tochigi II and Nagoya: two additional molecular defects with ala-600-thr replacement found in plasmin light chain variants. J Biochem (Tokyo) 1984;96:277-287.
38. Nagayama T, Shinohara Y, Nagayama M, Tsuda M, Yamamura M: Congenitally abnormal plasminogen in juvenile ischemic cerebrovascular disease. Stroke 1993;24:2104-2107.
39. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-809.
40. Furlan AJ, Lucas FV, Craciun R, Wohl RC: Stroke in a young adult with familial plasminogen disorder. Stroke 1991;22:1598-1602.
41. Okamoto A, Sakata T, Mannami T, Baba S, Katayama Y, Matsuo H, Yasaka M, Minematsu K, Tomoike H, Miyata T: Population-based distribution of plasminogen activity and estimated prevalence and relevance to thrombotic diseases of plasminogen deficiency in the Japanese: the Suita Study. J Thromb Haemost 2003;1:2397-2403.
42. Biemond BJ, Friederich PW, Koschinsky ML, Levi M, Sangrar W, Xia J, Buller HR, ten Cate JW: Apolipoprotein(a) attenuates endogenous fibrinolysis in the rabbit jugular vein thrombosis model in vivo. Circulation 1997;96:1612-1615.